Mutations in two regions upstream of the A gamma globin gene canonical promoter affect gene expression.

AUTOR(ES)

Lloyd, J A

RESUMO

Two regions upstream of the human fetal (A gamma) globin gene, which interact with protein factors from K562 and HeLa nuclear extracts, have functional significance in gene expression. One binding site (site I) is at a position -290 to -267 bp upstream of the transcription initiation site, the other (site II) is at -182 to -168 bp. Site II includes the octamer sequence (ATGCAAAT) found in an immunoglobulin enhancer and the histone H2b gene promoter. A point mutation (T----C) at -175, within the octamer sequence, is characteristic of a naturally occurring HPFH (hereditary persistence of fetal hemoglobin), and decreases factor binding to an oligonucleotide containing the octamer motif. Expression assays using a A gamma globin promoter-CAT (chloramphenicol acetyl transferase) fusion gene show that the point mutation at -175 increases expression in erythroid, but not non-erythroid cells when compared to a wild-type construct. This correlates with the actual effect of the HPFH mutation in humans. This higher expression may result from a mechanism more complex than reduced binding of a negative regulator. A site I clustered-base substitution gives gamma-CAT activity well below wild-type, suggesting that this factor is a positive regulator.

Documentos Relacionados

• Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes.
• Fate of a redundant gamma-globin gene in the atelid clade of New World monkeys: implications concerning fetal globin gene expression.
• Role of gene order in developmental control of human gamma- and beta-globin gene expression.
• Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.
• Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression.